Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii

Drug resistance is a public health concern that threatens to undermine decades of medical progress. ESKAPE pathogens cause most nosocomial infections, and are frequently resistant to carbapenem antibiotics, usually leaving tigecycline and colistin as the last treatment options. However, increasing t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Adv
Auteurs principaux: Nagarajan, Deepesh, Roy, Natasha, Kulkarni, Omkar, Nanajkar, Neha, Datey, Akshay, Ravichandran, Sathyabaarathi, Thakur, Chandrani, T., Sandeep, Aprameya, Indumathi V., Sarma, Siddhartha P., Chakravortty, Dipshikha, Chandra, Nagasuma
Format: Artigo
Langue:Inglês
Publié: American Association for the Advancement of Science 2019
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656545/
https://ncbi.nlm.nih.gov/pubmed/31355341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aax1946
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires